Neu1 inhibition by oseltamivir phosphate has been shown to specifically increase E-cadherin expression and to decrease N-cadherin expression in pancreatic cancer [30, 46], triple-negative breast cancer [112] and in ovarian tumor models [206]. The gene discussed is CDH2; the disease is triple-negative breast carcinoma.